International Clinical Trial: A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135544) titled 'A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer' on Aug. 14.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Yongjun Chen

Condition: Biliary Tract Cancer Biliary Tract Cancer (CCA)

Intervention: Drug: Adebrelimab combined with the GC regimen and Apatinib

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: August 14, 2025

Target Sample Size: 37

Countr...